| NCT Number | NCT07504263 |
| Lead Sponsor | Recurv Pharma Inc |
| Conditions | Advanced Malignancies, Oncology, Colorectal Cancer, Pancreatic Cancer, Cancer |
| Enrollment | 66 participants |
| Start Date | 2026-04-23 |
| Primary Completion | 2027-12-01 (estimated) |
| Study Completion | 2028-04-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-31 |